The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global 4 Factor Pro-thrombin Complex Concentrate Market Research Report 2024
Synopsis
The 4-factor prothrombin complex concentrate (4F-PCC), which contains the human coagulation factors II, VII, IX and X together with the endogenous inhibitor proteins S and C, is indicated for the urgent reversal of acquired coagulation factor deficiency induced by VKA (e.g. warfarin or coumarin) therapy in adult
Global 4 Factor Pro-thrombin Complex Concentrate market is projected to reach US$ 1833.5 million in 2029, increasing from US$ 850 million in 2022, with the CAGR of 11.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole 4 Factor Pro-thrombin Complex Concentrate market research.
The market factors is increasing prescription of anticoagulants, especially warfarin, as well as rising prevalence of bleeding disorders. Additionally, PCC offers various advantages over Fresh-frozen plasma and others, making it a more suitable option for life-threatening conditions. Apart from this, active government support for the use of 4-factor PCC products such as Kcentra and positive recommendations are anticipated to provide considerable momentum to the market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global 4 Factor Pro-thrombin Complex Concentrate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
CSL Behring
Octapharma
Prothya Biosolutions
Takeda
Segment by Type
Beriplex
Octaplex
Prothromplex
Cofact
Other
Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The 4 Factor Pro-thrombin Complex Concentrate report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
The 4-factor prothrombin complex concentrate (4F-PCC), which contains the human coagulation factors II, VII, IX and X together with the endogenous inhibitor proteins S and C, is indicated for the urgent reversal of acquired coagulation factor deficiency induced by VKA (e.g. warfarin or coumarin) therapy in adult
Global 4 Factor Pro-thrombin Complex Concentrate market is projected to reach US$ 1833.5 million in 2029, increasing from US$ 850 million in 2022, with the CAGR of 11.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole 4 Factor Pro-thrombin Complex Concentrate market research.
The market factors is increasing prescription of anticoagulants, especially warfarin, as well as rising prevalence of bleeding disorders. Additionally, PCC offers various advantages over Fresh-frozen plasma and others, making it a more suitable option for life-threatening conditions. Apart from this, active government support for the use of 4-factor PCC products such as Kcentra and positive recommendations are anticipated to provide considerable momentum to the market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global 4 Factor Pro-thrombin Complex Concentrate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
CSL Behring
Octapharma
Prothya Biosolutions
Takeda
Segment by Type
Beriplex
Octaplex
Prothromplex
Cofact
Other
Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The 4 Factor Pro-thrombin Complex Concentrate report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 4 Factor Pro-thrombin Complex Concentrate Market Overview
1.1 Product Overview and Scope of 4 Factor Pro-thrombin Complex Concentrate
1.2 4 Factor Pro-thrombin Complex Concentrate Segment by Type
1.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Market Value Comparison by Type (2023-2029)
1.2.2 Beriplex
1.2.3 Octaplex
1.2.4 Prothromplex
1.2.5 Cofact
1.2.6 Other
1.3 4 Factor Pro-thrombin Complex Concentrate Segment by Application
1.3.1 Global 4 Factor Pro-thrombin Complex Concentrate Market Value by Application: (2023-2029)
1.3.2 Hemophilia B
1.3.3 Acquired Coagulation Factor Deficiency
1.4 Global 4 Factor Pro-thrombin Complex Concentrate Market Size Estimates and Forecasts
1.4.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue 2018-2029
1.4.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales 2018-2029
1.4.3 Global 4 Factor Pro-thrombin Complex Concentrate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 4 Factor Pro-thrombin Complex Concentrate Market Competition by Manufacturers
2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Manufacturers (2018-2023)
2.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Manufacturers (2018-2023)
2.3 Global 4 Factor Pro-thrombin Complex Concentrate Average Price by Manufacturers (2018-2023)
2.4 Global 4 Factor Pro-thrombin Complex Concentrate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of 4 Factor Pro-thrombin Complex Concentrate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 4 Factor Pro-thrombin Complex Concentrate, Product Type & Application
2.7 4 Factor Pro-thrombin Complex Concentrate Market Competitive Situation and Trends
2.7.1 4 Factor Pro-thrombin Complex Concentrate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 4 Factor Pro-thrombin Complex Concentrate Players Market Share by Revenue
2.7.3 Global 4 Factor Pro-thrombin Complex Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 4 Factor Pro-thrombin Complex Concentrate Retrospective Market Scenario by Region
3.1 Global 4 Factor Pro-thrombin Complex Concentrate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global 4 Factor Pro-thrombin Complex Concentrate Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2018-2029
3.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2018-2023
3.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2024-2029
3.3 Global 4 Factor Pro-thrombin Complex Concentrate Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region: 2018-2029
3.3.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region: 2018-2023
3.3.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region: 2024-2029
3.4 North America 4 Factor Pro-thrombin Complex Concentrate Market Facts & Figures by Country
3.4.1 North America 4 Factor Pro-thrombin Complex Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2018-2029)
3.4.3 North America 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe 4 Factor Pro-thrombin Complex Concentrate Market Facts & Figures by Country
3.5.1 Europe 4 Factor Pro-thrombin Complex Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2018-2029)
3.5.3 Europe 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Market Facts & Figures by Country
3.6.1 Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2018-2029)
3.6.3 Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 4 Factor Pro-thrombin Complex Concentrate Market Facts & Figures by Country
3.7.1 Latin America 4 Factor Pro-thrombin Complex Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2018-2029)
3.7.3 Latin America 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Market Facts & Figures by Country
3.8.1 Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2018-2029)
3.8.3 Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2018-2029)
4.1.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2018-2023)
4.1.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2024-2029)
4.1.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Type (2018-2029)
4.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2018-2029)
4.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2018-2023)
4.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2024-2029)
4.2.3 Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Type (2018-2029)
4.3 Global 4 Factor Pro-thrombin Complex Concentrate Price by Type (2018-2029)
5 Segment by Application
5.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2018-2029)
5.1.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2018-2023)
5.1.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2024-2029)
5.1.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Application (2018-2029)
5.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2018-2029)
5.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2018-2023)
5.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2024-2029)
5.2.3 Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Application (2018-2029)
5.3 Global 4 Factor Pro-thrombin Complex Concentrate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring 4 Factor Pro-thrombin Complex Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CSL Behring 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Octapharma
6.2.1 Octapharma Corporation Information
6.2.2 Octapharma Description and Business Overview
6.2.3 Octapharma 4 Factor Pro-thrombin Complex Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Octapharma 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
6.2.5 Octapharma Recent Developments/Updates
6.3 Prothya Biosolutions
6.3.1 Prothya Biosolutions Corporation Information
6.3.2 Prothya Biosolutions Description and Business Overview
6.3.3 Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
6.3.5 Prothya Biosolutions Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Corporation Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda 4 Factor Pro-thrombin Complex Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takeda 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
6.4.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 4 Factor Pro-thrombin Complex Concentrate Industry Chain Analysis
7.2 4 Factor Pro-thrombin Complex Concentrate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 4 Factor Pro-thrombin Complex Concentrate Production Mode & Process
7.4 4 Factor Pro-thrombin Complex Concentrate Sales and Marketing
7.4.1 4 Factor Pro-thrombin Complex Concentrate Sales Channels
7.4.2 4 Factor Pro-thrombin Complex Concentrate Distributors
7.5 4 Factor Pro-thrombin Complex Concentrate Customers
8 4 Factor Pro-thrombin Complex Concentrate Market Dynamics
8.1 4 Factor Pro-thrombin Complex Concentrate Industry Trends
8.2 4 Factor Pro-thrombin Complex Concentrate Market Drivers
8.3 4 Factor Pro-thrombin Complex Concentrate Market Challenges
8.4 4 Factor Pro-thrombin Complex Concentrate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
